Community-Acquired Pneumonia Treatment Approach

Initial Treatment

The initial treatment approach for community-acquired pneumonia (CAP) in adults should be based on the setting of care, severity of illness, and patient risk factors, with empiric antibiotic therapy tailored to cover the most likely pathogens while considering local resistance patterns, as recommended by the American College of Physicians 1
Determine the appropriate setting for treatment using validated severity assessment tools, considering the presence of comorbidities, risk factors for drug-resistant pathogens, and severity of illness at presentation, according to the Infectious Diseases Society of America 2, 1, 3, 4

For healthy adults without comorbidities, the first choice of antibiotic is Amoxicillin 1 g three times daily, as recommended by the American College of Physicians 1
For adults with comorbidities, combination therapy with Amoxicillin/clavulanate or a cephalosporin, plus a macrolide or doxycycline, is recommended, according to the American Thoracic Society 1
Inpatient treatment should include a β-lactam plus a macrolide, or a respiratory fluoroquinolone alone, as suggested by the Infectious Diseases Society of America 1, 2

For patients without risk factors for Pseudomonas aeruginosa, a non-antipseudomonal β-lactam plus a macrolide or a respiratory fluoroquinolone is recommended, according to the American College of Chest Physicians 1
For patients with risk factors for Pseudomonas aeruginosa, an antipseudomonal β-lactam plus either ciprofloxacin or a macrolide plus an aminoglycoside is recommended, as suggested by the Infectious Diseases Society of America 2, 1

Patients should be treated for a minimum of 5 days and should be afebrile for 48-72 hours and have no more than 1 CAP-associated sign of clinical instability before discontinuation of therapy, according to the Infectious Diseases Society of America 2, 1
Patients can be switched from intravenous to oral therapy when they are hemodynamically stable and improving clinically, able to ingest medications, and have a normally functioning gastrointestinal tract, as recommended by the American College of Physicians 2

For suspected or confirmed influenza pneumonia, oseltamivir should be added to the treatment regimen, as suggested by the Centers for Disease Control and Prevention 2
For suspected H5N1 infection, treatment with oseltamivir and antibacterial agents targeting S. pneumoniae and S. aureus is recommended, according to the World Health Organization 2

Delayed antibiotic administration can increase mortality, and overuse of fluoroquinolones should be avoided to prevent development of resistance, as warned by the American College of Physicians 1
Inadequate coverage of causative pathogens is associated with worse outcomes, and relying solely on clinical presentation without radiographic confirmation can lead to misdiagnosis, according to the Infectious Diseases Society of America 1